Florence Hofman

Affiliations: 
Pathobiology University of Southern California, Los Angeles, CA, United States 
Area:
Pathology, Microbiology Biology
Google:
"Florence Hofman"

Children

Sign in to add trainee
Christiana Charalambous grad student 2005 USC
Jun Zuo grad student 2006 USC
Chieh-Fang Cheng grad student 2008 USC
Jenilyn J. Virrey grad student 2009 USC
Dennis To grad student 2011 USC
Nadya Andini grad student 2012 USC
Scott A. Bergfeld grad student 2013 USC
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ou M, Cho HY, Fu J, et al. (2023) Inhibition of autophagy and induction of glioblastoma cell death by NEO214, a perillyl alcohol-rolipram conjugate. Autophagy. 1-20
Minea RO, Duc TC, Swenson SD, et al. (2020) Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas. Plos One. 15: e0238238
Marín-Ramos NI, Pérez-Hernández M, Tam A, et al. (2019) Inhibition of motility by NEO100 through the calpain-1/RhoA pathway. Journal of Neurosurgery. 1-12
Wang W, Swenson S, Cho HY, et al. (2019) Efficient brain targeting and therapeutic intracranial activity of bortezomib through intranasal co-delivery with NEO100 in rodent glioblastoma models. Journal of Neurosurgery. 1-9
Peng L, Fu J, Wang W, et al. (2019) Distribution of cancer stem cells in two human brain gliomas. Oncology Letters. 17: 2123-2130
Cho HY, Thein TZ, Wang W, et al. (2019) The Rolipram-Perillyl Alcohol Conjugate (NEO214) Is A Mediator Of Cell Death Through The Death Receptor Pathway. Molecular Cancer Therapeutics
Swenson S, Silva-Hirschberg C, Wang W, et al. (2018) NEO412: A temozolomide analog with transdermal activity in melanoma and . Oncotarget. 9: 37026-37041
Marín-Ramos NI, Jhaveri N, Thein TZ, et al. (2018) NEO212, a conjugate of temozolomide and perillyl alcohol, blocks the endothelial-to-mesenchymal transition in tumor-associated brain endothelial cells in glioblastoma. Cancer Letters
Chen TC, Chan N, Minea RO, et al. (2018) Rare Stochastic Expression of O6-Methylguanine- DNA Methyltransferase (MGMT) in MGMT-Negative Melanoma Cells Determines Immediate Emergence of Drug-Resistant Populations upon Treatment with Temozolomide In Vitro and In Vivo. Cancers. 10
Bota DA, Chung J, Dandekar M, et al. (2018) Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4 T-lymphocyte counts. Cns Oncology
See more...